Literature DB >> 14749025

Sensitization to palladium chloride: a 10-year evaluation.

Francesca Larese Filon1, Daniele Uderzo, Emma Bagnato.   

Abstract

BACKGROUND: Palladium is increasingly used in industry, jewelry, and dentistry and is becoming more common since the European directive restricting the use of nickel in all products placed in direct and prolonged contact with the skin.
OBJECTIVE: The role of palladium sensitization is still unclear, and the aim of our study is to evaluate the trend of sensitization in a contact dermatitis clinic population during a 10-year period.
METHODS: We report our experience with 4,446 patients (3,077 female, 1,369 male; mean age, 40.1 +/-13.7 years) with suspected contact dermatitis patch-tested during the period of 1991 to 2000.
RESULTS: A positive patch-test result to palladium chloride 1% was indicated in 236 patients (5.3%), with a higher percentage in females (6.7%) than in males (2.3%), and the sensitization to this metal has increased over the specified period, to a maximum in the year 2000 (9.7%). In the majority of cases, subjects were polysensitized (92.8%), but 7.2% of subjects were patch-test positive only to palladium. Of palladium-sensitized patients, 40.5% complained of hand dermatitis, 47.4% complained of body dermatitis, and 1.7% complained of burning mouth syndrome. Palladium sensitization is significantly related to female sex (OR = 3.08; 95% CI, 2.07-4.61) and to sensitization to other metals, with a maximum for nickel sulfate (OR = 32.9; 95% CI, 21.3-51.5).
CONCLUSION: Sensitization to palladium is increasing by the year, reaching high values, but its role in reducing sensitization and symptoms is still unclear because of the frequent cosensitization with nickel and the low number of monosensitized patients with relevant sensitizations. We need to follow palladium sensitization in future years to verify an increase of sensitization due to the increasing use of this metal.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14749025

Source DB:  PubMed          Journal:  Am J Contact Dermat        ISSN: 1046-199X


  5 in total

1.  Usefulness of lymphocyte transformation test and in vitro cytokine release in differentiating between independent and cross-reacting nickel/palladium allergy.

Authors:  Florian Kapp; Burkhard Summer; Peter Thomas
Journal:  Immun Inflamm Dis       Date:  2020-07-28

2.  NKG2D⁺ IFN-γ⁺ CD8⁺ T cells are responsible for palladium allergy.

Authors:  Mitsuko Kawano; Masafumi Nakayama; Yusuke Aoshima; Kyohei Nakamura; Mizuho Ono; Tadashi Nishiya; Syou Nakamura; Yuri Takeda; Akira Dobashi; Akiko Takahashi; Misato Endo; Akiyo Ito; Kyosuke Ueda; Naoki Sato; Shigehito Higuchi; Takeru Kondo; Suguru Hashimoto; Masamichi Watanabe; Makoto Watanabe; Tetsu Takahashi; Keiichi Sasaki; Masanori Nakamura; Takehiko Sasazuki; Takayuki Narushima; Ryuji Suzuki; Kouetsu Ogasawara
Journal:  PLoS One       Date:  2014-02-12       Impact factor: 3.240

3.  Palladium nanoparticles induce disturbances in cell cycle entry and progression of peripheral blood mononuclear cells: paramount role of ions.

Authors:  Claudia Petrarca; Emanuela Clemente; Luca Di Giampaolo; Renato Mariani-Costantini; Kerstin Leopold; Roland Schindl; Lavinia V Lotti; Rocco Mangifesta; Enrico Sabbioni; Qiao Niu; Giovanni Bernardini; Mario Di Gioacchino
Journal:  J Immunol Res       Date:  2014-07-03       Impact factor: 4.818

4.  Exposure to Palladium Nanoparticles Affects Serum Levels of Cytokines in Female Wistar Rats.

Authors:  Ivo Iavicoli; Luca Fontana; Maddalena Corbi; Veruscka Leso; Alessandro Marinaccio; Kerstin Leopold; Roland Schindl; Alessandro Sgambato
Journal:  PLoS One       Date:  2015-11-30       Impact factor: 3.240

5.  Fexofenadine Suppresses Delayed-Type Hypersensitivity in the Murine Model of Palladium Allergy.

Authors:  Ryota Matsubara; Kenichi Kumagai; Hiroaki Shigematsu; Kazutaka Kitaura; Yasunari Nakasone; Satsuki Suzuki; Yoshiki Hamada; Ryuji Suzuki
Journal:  Int J Mol Sci       Date:  2017-06-25       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.